This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The first drug to treat desmoid tumors shrank tumors in 41 percent of participants and improved quality of life with few side effects.
